SEC Form 5 · accession 0001570523-18-000010
Immune Therapeutics, Inc. · IMUN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Period of report
Dec 31, 2017
Accepted (ET)
Mar 29, 2018 · 8:34 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001559356
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock | Jan 5, 2016 | P | 5,000 | $0.189 | A | 20,800,359 | D | |
| Common stock | Jan 7, 2016 | P | 975 | $0.1712 | A | 20,800,359 | D | |
| Common stock | Jan 7, 2016 | P | 10,025 | $0.17 | A | 20,800,359 | D | |
| Common stock | Jan 12, 2016 | P | 2,000 | $0.1846 | A | 20,800,359 | D | |
| Common stock | Jan 12, 2016 | P | 5,000 | $0.185 | A | 20,800,359 | D | |
| Common stock | Jan 13, 2016 | P | 1,000 | $0.1889 | A | 20,800,359 | D | |
| Common stock | Jan 15, 2016 | P | 500 | $0.2102 | A | 20,800,359 | D | |
| Common stock | Jan 15, 2016 | P | 500 | $0.2104 | A | 20,800,359 | D | |
| Common stock | Jan 15, 2016 | P | 1,000 | $0.2103 | A | 20,800,359 | D | |
| Common stock | Jan 15, 2016 | P | 500 | $0.215 | A | 20,800,359 | D | |
| Common stock | Jan 15, 2016 | P | 200 | $0.204 | A | 20,800,359 | D | |
| Common stock | Jan 15, 2016 | P | 400 | $0.2099 | A | 20,800,359 | D | |
| Common stock | Jan 15, 2016 | P | 300 | $0.2099 | A | 20,800,359 | D | |
| Common stock | Jan 19, 2016 | P | 5,000 | $0.2085 | A | 20,800,359 | D | |
| Common stock | Jan 19, 2016 | P | 2,000 | $0.21 | A | 20,800,359 | D | |
| Common stock | Jan 20, 2016 | P | 5,000 | $0.2075 | A | 20,800,359 | D | |
| Common stock | Jan 20, 2016 | P | 500 | $0.2002 | A | 20,800,359 | D | |
| Common stock | Jan 20, 2016 | P | 100 | $0.2081 | A | 20,800,359 | D | |
| Common stock | Jan 20, 2016 | P | 100 | $0.209 | A | 20,800,359 | D | |
| Common stock | Jan 21, 2016 | P | 17,500 | $0.1999 | A | 20,800,359 | D | |
| Common stock | Jan 21, 2016 | P | 500 | $0.205 | A | 20,800,359 | D | |
| Common stock | Jan 25, 2016 | P | 200 | $0.205 | A | 20,800,359 | D | |
| Common stock | Jan 25, 2016 | P | 1,250 | $0.1998 | A | 20,800,359 | D | |
| Common stock | Jan 25, 2016 | P | 250 | $0.1999 | A | 20,800,359 | D | |
| Common stock | Jan 25, 2016 | P | 1,000 | $0.1998 | A | 20,800,359 | D | |
| Common stock | Jan 25, 2016 | P | 1,000 | $0.1998 | A | 20,800,359 | D | |
| Common stock | Jan 26, 2016 | P | 500 | $0.1969 | A | 20,800,359 | D | |
| Common stock | Jan 26, 2016 | P | 1,000 | $0.1991 | A | 20,800,359 | D | |
| Common stock | Jan 26, 2016 | P | 1,000 | $0.1991 | A | 20,800,359 | D | |
| Common stock | Jan 27, 2016 | P | 300 | $0.189 | A | 20,800,359 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
This is part 6 of 16 submissions.